No Picture
News

DCN Dx Announces Hiring of Mitzi Rettinger as Chief Revenue Officer

CARLSBAD, Calif.: CARLSBAD, Calif., Jan. 24, 2022 /PRNewswire/ — DCN Dx announced today that Mitzi Rettinger has been hired as chief revenue officer reporting directly to Chief Executive Officer Charlie Mamrak. "Mitzi brings decades of sales and marketing experience to the chief revenue officer role," Mamrak said. "She is a… Click here to view original post… […]

No Picture
News

Viking Therapeutics Announces Clinical Hold on Phase 1b Trial of VK0214 in Patients with X-ALD

SAN DIEGO: SAN DIEGO, Jan. 24, 2022 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its Phase 1b clinical trial of VK0214 in patients with X-linked adrenoleukodystrophy (X-ALD) has been placed… Click here to view original post… […]

No Picture
News

Ionis announces eplontersen receives orphan drug designation from U.S. FDA

CARLSBAD, Calif.: CARLSBAD, Calif., Jan. 24, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in antisense therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to eplontersen, an investigational antisense medicine for the treatment of people living with transthyretin-mediated amyloidosis, a… Click here to view original post… […]

No Picture
News

Arcturus Therapeutics Updates Data from ARCT-154 and ARCT-165 Booster Clinical Trial Demonstrating Robust Neutralizing Antibody Responses to SARS-CoV-2 and Several Variants

SAN DIEGO–(BUSINESS WIRE)—- $ARCT #ClinicalTrial–Arcturus Updates Data from ARCT-154 and ARCT-165 Booster Clinical Trial Demonstrating Robust Neutralizing Antibody Responses to SARS-CoV-2 Click here to view original post… […]

No Picture
Uncategorized

Scientist, Gene Therapy Cell Line Development – R-100738 – San Diego, CA – National Resilience – National City, CA

This role will be responsible advancing Resilience R&D’s knowledge of cell line development for vector production through innovative experimental design and…From National Resilience – Fri, 21 Jan 2022 22:38:09 GMT – View all National City, […]

No Picture
Uncategorized

Scientist, Gene Therapy Analytical Development – R-100737 – San Diego, CA – National Resilience – National City, CA

This role will be responsible advancing Resilience R&D’s knowledge of gene therapy analytical methods through innovative experimental design and efficient…From National Resilience – Fri, 21 Jan 2022 22:36:25 GMT – View all National City, CA […]

No Picture
News

Salk appoints Julie A. Auger executive director of Research Operations

LA JOLLA—The Salk Institute announced today the appointment of Julie A. Auger to the position of executive director of Research Operations. Auger will oversee all shared scientific resources at the Institute in her new role, including the scientific technology cores, animal research and shared scientific resources. The position reports… Click here to view original post… […]

No Picture
News

Mirati Therapeutics Presents Positive Clinical Data with Investigational Adagrasib in Patients with KRASG12C-Mutated Gastrointestinal Cancers

SAN DIEGO: SAN DIEGO, Jan. 21, 2022 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced positive results from a Phase 2 cohort of the KRYSTAL-1 study evaluating adagrasib at the 600mg BID dose in patients with pretreated pancreatic ductal adenocarcinoma and other gastrointestinal (GI)… Click here to view original post… […]

No Picture
News

As Hal Barron steals the show, there’s no off position on the John Maraganore switch; Danny Bar-Zohar makes another leap forward at Merck KGaA

John Maraganore ? The needle on the Maraganore Meter is moving again, as John Maraganore keeps collecting more post-Alnylam roles. First, he and BeiGene co-founder Peter Ho will be strategic advisors for Hillhouse-backed China startup Overland Pharmaceuticals, founded by Hua Mu and Ed Zhang. (By the… Click here to view original post… […]

No Picture
Uncategorized

Scientist, Gene Therapy Analytical Development – R-100737 – San Diego, CA – National Resilience – La Mesa, CA

This role will be responsible advancing Resilience R&D’s knowledge of gene therapy analytical methods through innovative experimental design and efficient…From National Resilience – Fri, 21 Jan 2022 05:50:41 GMT – View all La Mesa, CA […]

No Picture
Uncategorized

Analytical Scientist, Bioanalytical Assay Development – Cellics Therapeutics, Inc. – San Diego, CA

Cellics Therapeutics is seeking an Analytical Scientist to support the Bioanalytical Assay Development team. Conduct analytical testing, collect analytical data…From Indeed – Fri, 21 Jan 2022 01:26:22 GMT – View all San Diego, CA jobsClick […]

No Picture
News

Regulus Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA for RGLS8429

SAN DIEGO: SAN DIEGO, Jan. 20, 2022 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that the Company has completed a pre-investigational new drug (Pre-IND) meeting with the U.S. Food and… Click here to view original post… […]

No Picture
News

A high-res microscope the size of a toaster? A microscopy startup earns big-name VC backers

When Bo Jing enrolled at Oxford University to be close to his girlfriend, he didn’t expect to invent something that would have investors eagerly digging into their wallets. He was just happy making the best microscope he could. He developed the technology while finishing up his PhD at Oxford, and… Click here to view original post… […]